Effectiveness and safety of nirmatrelvir+ritonavir in COVID-19. NiRCoV Study: Correspondence H. Daungsupawong; V. Wiwanitkit;

Leukocytoclastic vasculitis and COVID-19 vaccination P. Sookaromdee; V. Wiwanitkit;